VolitionRx, a Singapore-based medical technology venture that plans to bring low-cost cancer diagnostics tests to the masses, might be looking at a potential funding of up to $12 million.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
